Tokyo startup confirms efficacy of iPS cell-derived heart muscle transplants
A medical trial by a Tokyo-based enterprise firm originating from Keio College has confirmed that transplanting cardiac muscle cell clusters ...
- Latest
A medical trial by a Tokyo-based enterprise firm originating from Keio College has confirmed that transplanting cardiac muscle cell clusters ...
SAN FRANCISCO: An Indian medical innovation has achieved a significant world recognition with a brand new technology coronary heart stent ...
Train has vital advantages for coronary heart well beingIan Canham/Alamy Males over 50 could should train greater than twice as ...
Copyright © 2022 Asia Today.